MRSA Research in Bristol

The latest issue of Eurosurveillance, Europe’s journal on infectious diseases, features recent research into the prevalence of MRSA among people who inject drugs in “the Bristol clade”.

The study took place between 2012 and 2017 with research partners including Public Health England, National Institute for Health Research, the University of West England and the University of Bristol.

BDP played a significant part in this research project, helping recruit participants through our Needle Exchange located across the city and playing the part of a testing site.

At BDP we are continuing to work towards reducing harm cause by MRSA. We are currently involved in a Design in the Public Sector programme aiming to help local governments and partner organisations use design processes and methods to tackle public health challenges like MRSA.

Read MRSA study

1 minute read

Related to this article

National Harm Reduction Summit 2026

Bristol Drug Project

National Harm Reduction Summit 2026

That’s a wrap on our National Harm Reduction Summit in partnership with The Hepatitis C Trust! Across two inspiring days, ...

Are you a former BDP Trustee?

Bristol Drug Project

Are you a former BDP Trustee?

As part of our 40th anniversary celebrations, BDP is looking to connect with former trustees. Trusteeship is a vital role w...

BDP Launches New 5 Year Strategy

Bristol Drug Project

BDP Launches New 5 Year Strategy

We are very happy to announce the release of our ambitious new 5 year strategy taking us through from 2026 to 2031. Read on ...